Product Concept Testing Study for a Global Pharma Company |
 | A global pharmaceutical company wanted to promote their novel fixed dose combination diabetes pill in the Thailand market. Read more to learn how Oncofocus helped client in understanding the initial impressions of the physicians and assess the market preferences. |
0 Comments
 | February is the designated month for spreading awareness on Gall Bladder cancer. We present an infographic comparing the incidence and mortality data of Gall Bladder in the APAC vs RoW. |
When compared to the Rest of the World, a clear spike (>30%) in the mortality related disease burden is expected in the APAC 11 by the year 2040.
Cervical Cancer Screening Awareness Survey (Focus: US)
The recent report in 2018 by the US Preventive Services Task Force (USPSTF) shows that the cervical cancer related mortality has substantially decreased due to screening programmes. The report mentions that number of deaths have declined from 2.8 to 2.3 per 100,000 women from 2000 to 2015.
We did an online survey in this month in the US to understand following -
- do educated adult (18 years or above) Americans, who are aware about Cervical cancer, themselves go (in case of female) OR take their family members for regular screening (in case of both male and female)?
- what are the key reasons behind not going for the voluntary screening?
Cervical Cancer Awareness Month - QnA Session with an Expert (2/2)
(Focus: Malaysia)
For our second Cervical cancer interview, we discussed with Dr. Lim Chun Sen, a leading Malaysian Oncologist, his experience in treating Cervical cancer patients, challenges with diagnosis, and key future trends in Cervical cancer screening and management.
Dr. Lim Chun Sen is a Clinical Oncologist since 2014 and is presently managing the department of Oncology in Hospital Sultan Ismail, Malaysia.
Dr. Lim Chun Sen is a Clinical Oncologist since 2014 and is presently managing the department of Oncology in Hospital Sultan Ismail, Malaysia.
Cervical Cancer Awareness Month - QnA Session with an Expert (1/2)
(Focus: India)
January is designated for raising awareness on Cervical cancer. We interviewed Dr. Rahul Roy Chowdhury, a leading Oncologist, to understand the current practice, challenges, and future trends in Cervical cancer screening and management.
Dr. Rahul Roy Chowdhury has been practicing as a Gynecological Oncologist for several years, following his training in the United Kingdom as a Gynecologist and an Oncologist. Along with his practice, he is involved in multiple clinical trials and is keenly interested in research activities.
Dr. Rahul Roy Chowdhury has been practicing as a Gynecological Oncologist for several years, following his training in the United Kingdom as a Gynecologist and an Oncologist. Along with his practice, he is involved in multiple clinical trials and is keenly interested in research activities.
Campaign Effectiveness Tracker for a US based Vaccine Company
(Focus: Philippines)
 | A US-based vaccine company newly launched its HPV vaccine in the Philippines. It ran targeted campaign to increase awareness about their vaccine. Read more to learn how we supported our client in tracking the campaign effectiveness among the HCPs. |
Evolution of Molecular Diagnostics Market - An Expert's Perspective (#2)
(Focus: India)
For our second interview in the "Evolution of Molecular Diagnostics Market - An Expert's Perspective" series, we interviewed Mr. Rajendra, Quality Assurance Manager, Strand Life Sciences, Bengaluru. Read this interview to learn about his experience and observations regarding the Indian cancer molecular diagnostics space.
 | Mr. Rajendra Kumar G S Quality Assurance Manager Strand Life Sciences, Bengaluru |
 | To mark the 'Cervical Cancer Awareness month', we present an infographic comparing the incidence and mortality data of Cervical cancer cases in the APAC vs RoW. |
By 2040, the mortality-related disease burden in the APAC11 countries will be similar to that in the Rest of the World (RoW), thus, indicating towards the high burden of Cervical cancer in this region.
Evolution of Molecular Diagnostics Market - An Expert's Perspective (#1)
(Focus: India)
Wishing all of our readers a great start to the year 2020!
We are kick-starting this year's 'Interview with an Expert' series with an insightful discussion with Dr. Ravi Gaur on the evolution and the dynamics of the cancer molecular diagnostics testing space in India.
Dr. Ravi Gaur is the Chief Operating Officer of Oncquest Labs and has more than 20 years of experience in the field of diagnostics. His stated goal is to make advanced diagnostics available at an affordable price and at doorstep of the customer.
Click on 'Read More' to learn about his views on how cancer molecular diagnostic testing space has evolved over the years and the key emerging trends and challenges in this segment.
We are kick-starting this year's 'Interview with an Expert' series with an insightful discussion with Dr. Ravi Gaur on the evolution and the dynamics of the cancer molecular diagnostics testing space in India.
Dr. Ravi Gaur is the Chief Operating Officer of Oncquest Labs and has more than 20 years of experience in the field of diagnostics. His stated goal is to make advanced diagnostics available at an affordable price and at doorstep of the customer.
Click on 'Read More' to learn about his views on how cancer molecular diagnostic testing space has evolved over the years and the key emerging trends and challenges in this segment.
 | Dr. Ravi Gaur AM, MBBS, MD, MS Chief Operating Officer (COO), Oncquest Labs Ltd., New Delhi, India |
Service Gap Assessment for a US-based Medical Device Company
(Focus: Singapore)
 | A US-based leading medical device manufacturer launched its new endoscopy product in Singapore. Read more to learn how we supported them in identifying and designing a differentiated after sales support policy. |